KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Net Income (2016 - 2025)

Historic Net Income for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Amgen's Net Income rose 11259.97% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.7 billion, marking a year-over-year increase of 8853.3%. This contributed to the annual value of $7.7 billion for FY2025, which is 8853.3% up from last year.
  • As of Q4 2025, Amgen's Net Income stood at $1.3 billion, which was up 11259.97% from $3.2 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's Net Income peaked at $3.2 billion during Q3 2025, and registered a low of -$113.0 million during Q1 2024.
  • Over the past 5 years, Amgen's median Net Income value was $1.5 billion (recorded in 2022), while the average stood at $1.5 billion.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 10397.75% in 2024, then skyrocketed by 163097.35% in 2025.
  • Quarter analysis of 5 years shows Amgen's Net Income stood at $1.9 billion in 2021, then fell by 14.9% to $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then skyrocketed by 112.6% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q4 2025, $3.2 billion for Q3 2025, and $1.4 billion during Q2 2025.